India
· Delayed Price · Currency is INR Poly Medicure Statistics
Total Valuation
Poly Medicure has a market cap or net worth of INR 254.17 billion. The enterprise value is 243.26 billion.
| Market Cap | 254.17B |
| Enterprise Value | 243.26B |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.46% |
| Shares Change (QoQ) | +3.55% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 31.24M |
Valuation Ratios
The trailing PE ratio is 80.67.
| PE Ratio | 80.67 |
| Forward PE | n/a |
| PS Ratio | 15.82 |
| PB Ratio | 9.81 |
| P/TBV Ratio | 10.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 77.21 |
| EV / Sales | 15.14 |
| EV / EBITDA | 57.24 |
| EV / EBIT | 68.09 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.38 |
| Debt / FCF | n/a |
| Interest Coverage | 28.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.48% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 2.55M |
| Profits Per Employee | 500,128 |
| Employee Count | 6,300 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +63.56% in the last 52 weeks. The beta is 0.22, so Poly Medicure's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +63.56% |
| 50-Day Moving Average | 2,227.78 |
| 200-Day Moving Average | 2,386.94 |
| Relative Strength Index (RSI) | 66.88 |
| Average Volume (20 Days) | 116,161 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Poly Medicure had revenue of INR 16.07 billion and earned 3.15 billion in profits. Earnings per share was 32.35.
| Revenue | 16.07B |
| Gross Profit | 10.64B |
| Operating Income | 3.54B |
| Pretax Income | 4.22B |
| Net Income | 3.15B |
| EBITDA | 4.20B |
| EBIT | 3.54B |
| Earnings Per Share (EPS) | 32.35 |
Balance Sheet
The company has 12.51 billion in cash and 1.61 billion in debt, giving a net cash position of 10.91 billion.
| Cash & Cash Equivalents | 12.51B |
| Total Debt | 1.61B |
| Net Cash | 10.91B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.91B |
| Book Value Per Share | 266.96 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 66.24%, with operating and profit margins of 22.04% and 19.61%.
| Gross Margin | 66.24% |
| Operating Margin | 22.04% |
| Pretax Margin | 26.27% |
| Profit Margin | 19.61% |
| EBITDA Margin | 26.16% |
| EBIT Margin | 22.04% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.12%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 0.12% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.46% |
| Shareholder Yield | -1.34% |
| Earnings Yield | 1.24% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 24, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 24, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |